INFEPERIUM Trademark

Trademark Overview

On Thursday, March 27, 2025, a trademark application was filed for INFEPERIUM with the United States Patent and Trademark Office. The USPTO has given the INFEPERIUM trademark a serial number of 99107847. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, March 27, 2025. The INFEPERIUM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development services in the field of antibodies; Scientific research in the field of immunotherapy; Scientific research in the field of Immunotherapy
infeperium

General Information

Serial Number99107847
Word MarkINFEPERIUM
Filing DateThursday, March 27, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, March 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesResearch and development services in the field of antibodies; Scientific research in the field of immunotherapy; Scientific research in the field of Immunotherapy

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 27, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressBoca Raton, FL 33434

Trademark Events

Event DateEvent Description
Thursday, March 27, 2025NEW APPLICATION ENTERED
Thursday, March 27, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

infeperium research field immunotherapy scientific antibodies development services